- Market Capitalization, $K 11,052,962
- Shares Outstanding, K 1,092,190
- Annual Sales, $ 16,659 M
- Annual Income, $ -3,990 M
- 60-Month Beta 1.46
- Price/Sales 0.68
- Price/Cash Flow 2.67
- Price/Book 1.03
|Period||Period Low||Period High||Performance|
| || |
-0.55 (-5.15%)since 05/18/21
| || |
-1.29 (-11.31%)since 03/18/21
| || |
-2.18 (-17.72%)since 06/18/20
The is segmented on the lines of its drug type, route of administration and regional. Basis of drug type is segmented into Acyclovir, Valacyclovir and Famciclovir. Based on route of administration it...
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced the U.S. launch of its generic version of once daily SOOLANTRA(R) (ivermectin) Cream,...
Teva Pharmaceutical Industries Ltd. (TEVA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher...
The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to discover innovative and effective therapies for the treatment...
The Global is estimated to value over USD 10.1 billion by 2027 end at a CAGR of over 6% during the forecast period 2020 to 2027.
The Global is poised to value over USD 37 billion by 2027 end at a CAGR of over 4.1% during the forecast period 2020 to 2027.
Building on its intention to improve the lives of Canadians, Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd, is pleased to announce the launch of Life Effects, a peer-to-peer support...
Japan, Japan, Fri, 04 Jun 2021 02:43:09 / Comserve Inc. / -- Global Losartan Market With Top Countries Data, Industry Analysis , Size, Share, Revenue, Prominent Players, Developing Technologies, Tendencies...
Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new data from clinical and real-world analyses examining the efficacy of AJOVY(R)...
Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that 11 presentations examining clinical and real-world data for AJOVY(R)...
|Teva Pharmaceutical Industries Ltd|
|Israel Vaneck ETF|
|Pharmaceutical Vaneck ETF|
|GS Activebeta International ETF|
|FTSE RAFI Dev Markets Ex-U.S. Invesco ETF|
|Pacer Trendpilot International ETF|
|3rd Resistance Point||10.63|
|2nd Resistance Point||10.50|
|1st Resistance Point||10.31|
|1st Support Level||9.99|
|2nd Support Level||9.86|
|3rd Support Level||9.67|